Search results
EBKDY vs. HDB: Which Stock Is the Better Value Option?
Zacks via Yahoo Finance· 1 day agoValue investors are also interested in a number of tried-and-true valuation metrics that help show...
CMPGY or CMG: Which Is the Better Value Stock Right Now?
Zacks via Yahoo Finance· 1 day agoThe Value category of the Style Scores system identifies undervalued companies by looking at a...
Kiora Pharmaceuticals director buys $25,668 in company stock By Investing.com
Investing.com· 3 hours agoKiora Pharmaceuticals Inc. (NASDAQ:KPRX) director Erin Parsons (NYSE:PSN) has recently invested...
Is Aptiv (APTV) Stock Undervalued Right Now?
Zacks via Yahoo Finance· 9 hours agoHere at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks....
SkyWest, Inc. (SKYW) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 10 hours agoDuring this period, the Zacks Transportation - Airline industry, which SkyWest falls in, has lost...
Is Now The Time To Put ICON (NASDAQ:ICLR) On Your Watchlist?
Simply Wall St. via Yahoo Finance· 9 hours agoYou might benefit from giving it a glance today. While opting for stocks without growing earnings...
Financial Services Roundup: Market Talk
The Wall Street Journal· 2 hours agoThe group changed its reporting methodology for the second time in two years, splitting interest income and moving from Ebitda to underlying pretax...
Forget Nvidia: 3 Artificial Intelligence (AI) Stocks to Buy Instead
Motley Fool via Yahoo Finance· 13 hours agoIt did $2.2 billion worth of business last year and turned a little over $200 million of that into...
Maddow Blog | Wednesday’s Mini-Report, 6.12.24
MSNBC via Yahoo News· 23 hours agoThat was also below expectations for an unchanged 3.4% reading.” * But Powell still isn’t cutting rates: “The Federal Reserve said Wednesday it was...
Down 57%, Is AbCellera Biologics a Buy on the Dip?
Motley Fool via Yahoo Finance· 13 hours agoTwo years later, less than 10% had advanced to clinical-stage testing. The company stopped reporting its total programs under contract this year, which...